Ozone Therapy Evidence
The article says ozone therapy has less financial backing than drug development because it lacks comparable pharmaceutical income potential. Prior ozone therapy discussions involving Frank Schallenberger and Robert Rowan are referenced. Th…
1 sources - 5 claims
The article says ozone therapy has less financial backing than drug development because it lacks comparable pharmaceutical income potential. Prior ozone therapy discussions involving Frank Schallenberger and Robert Rowan are referenced. The article describes the ozone therapy research base as strongest in Europe, especially Italy. Robert Rowan is described as having used ozone in Africa in connection with Ebola. Tuberculosis is mentioned as a serious condition where practitioners are exploring ozone-related possibilities.